Bank of New York Mellon’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $523K | Buy |
141,100
+6,251
| +5% | +$23.2K | ﹤0.01% | 3466 |
|
|
2025
Q1 | $436K | Sell |
134,849
-11,092
| -8% | -$35.8K | ﹤0.01% | 3500 |
|
|
2024
Q4 | $813K | Sell |
145,941
-464
| -0.3% | -$2.58K | ﹤0.01% | 3257 |
|
|
2024
Q3 | $1.58M | Sell |
146,405
-23,008
| -14% | -$249K | ﹤0.01% | 2862 |
|
|
2024
Q2 | $3.56M | Buy |
169,413
+38,015
| +29% | +$798K | ﹤0.01% | 2498 |
|
|
2024
Q1 | $4.19M | Sell |
131,398
-13,542
| -9% | -$431K | ﹤0.01% | 2403 |
|
|
2023
Q4 | $2.94M | Buy |
144,940
+9,229
| +7% | +$187K | ﹤0.01% | 2635 |
|
|
2023
Q3 | $1.73M | Buy |
135,711
+19,434
| +17% | +$247K | ﹤0.01% | 2892 |
|
|
2023
Q2 | $2.1M | Buy |
116,277
+7,822
| +7% | +$141K | ﹤0.01% | 2800 |
|
|
2023
Q1 | $1.86M | Sell |
108,455
-1,455
| -1% | -$25K | ﹤0.01% | 2841 |
|
|
2022
Q4 | $2.44M | Buy |
109,910
+2,693
| +3% | +$59.8K | ﹤0.01% | 2739 |
|
|
2022
Q3 | $862K | Buy |
107,217
+9,410
| +10% | +$75.7K | ﹤0.01% | 3278 |
|
|
2022
Q2 | $682K | Sell |
97,807
-3,515
| -3% | -$24.5K | ﹤0.01% | 3409 |
|
|
2022
Q1 | $1.53M | Buy |
101,322
+1,136
| +1% | +$17.2K | ﹤0.01% | 3077 |
|
|
2021
Q4 | $2.2M | Buy |
100,186
+30,968
| +45% | +$679K | ﹤0.01% | 2933 |
|
|
2021
Q3 | $1.87M | Buy |
69,218
+40,582
| +142% | +$1.09M | ﹤0.01% | 3014 |
|
|
2021
Q2 | $689K | Buy |
28,636
+8,219
| +40% | +$198K | ﹤0.01% | 3619 |
|
|
2021
Q1 | $885K | Buy |
+20,417
| New | +$885K | ﹤0.01% | 3398 |
|